Looking for a micro-cap company with significant investment potential? At Stock Day Media, we are highlighting the aqua-tech company, NaturalShrimp Inc., offering numerous assets, including disruptive patented technologies and a growth-driven strategy.
Who is NaturalShrimp Inc.?
NaturalShrimp Inc. is a publicly traded Biotechnology Aquaculture Company, trading under the ticker symbol ‘SHMP’, known for the development of its patented and proprietary commercially operational RAS (Recirculating Aquaculture System) technology, which is used to produce fresh, natural, and gourmet-grade shrimp without the use of antibiotics, probiotics, or toxic chemicals. NaturalShrimp first began in 2001, when it raised shrimp indoors with a 200-gallon recirculating system as a proof of concept. Today, the company now boasts multiple locations across the United States, including a 250,000 sq ft facility in Iowa and a 240,000 sq ft facility in Florida with an extensive expansion into Texas currently underway.
Despite being known for its ability to raise fresh shrimp indoors, one of the Company’s most valuable assets is its disruptive Fresh Seafood Technology. In fact, Natural Aquatic Systems is a NaturalShrimp wholly owned company designed to serve as a commercialization partner for its revolutionary aquaculture technologies known as Hydrogas™ and RLS™. According to the NaturalShrimp website, these technologies are next-generation, universal reducing agents that eliminate the industrial and biological problems caused by oxidation. Non-toxic and non-caustic, these technologies are also designed to be scalable and cost effective, offering an efficient solution to large-scale, high-volume problems, including corrosion, rust, low oxygenation, deficient ORP, ammonia, sour gas, high acidity, oil separation, salt and PCB contamination, bacterial growth, toxic wastewater, carbon emissions, low alkalinity, inhibited apoptosis, venomous enzymes, and putrefaction.
In an effort to validate their groundbreaking Aquaculture technology, NaturalShrimp has participated in numerous university and independent studies. A recent study involving university driven in-vivo testing of RLS™ provided the following results:
- Reduction of oxidative stress
- Increase of Superoxide Dismutase (SOD)
- Increase of Catalase
- Increase of Glutathione Content
- Bactericide and fungicide properties
- Residual effect when combined with Hydrogas
Meanwhile, the company recently completed testing at the Marineholmen RASLab in Norway to evaluate how their Hydrogas™ and electrocoagulation technologies compare with more traditional methods, which often consist of using a biofilter when raising salmon. The company is expecting positive results from this study, which are expected to lead to technology licensing opportunities with salmon and finfish producers around the world.
NaturalShrimp Inc. has also received permission to proceed with a trial in Australia in 2022, which will evaluate the removal of microalgae and total nitrogen in effluent water from prawn farms using their electrocoagulation technology.
Another key asset of NaturalShrimp is their dedication to growth, which has only continued despite past challenges and current economic hurdles. This micro-cap company is not only expanding its facilities and production capacity, but also continually expands its revenue potential by seeking to improve technology licensing opportunities through independent studies.
NaturalShrimp Inc. is also actively establishing its NaturalShrimp Outlet, which will the Company to receive and process their product for packaging and preparing shrimp for an online ordering and home delivery program.
With growing assets, patented and disruptive aquatic technology, and a proven dedication to building shareholder value, NaturalShrimp Inc. represents significant investment potential. To learn more about NaturalShrimp Inc. or to view the Company’s latest financial reports and corporate updates, please visit their website here: https://naturalshrimp.com. Investors can also keep up to date on NaturalShrimp’s latest updates with the Stock Day Podcast.